Gapping up
In reaction to strong earnings/guidance:
- TEX +10.5%, VEON +6.2%, MOGU +6%, CRI +5.5%, SSL +3.3%, PLAN +2.7%
M&A news:
- ONCE +120% (to be acquired by Roche for $114.50 per share)
- CMTA +75.6% (to be acquired by Ipsen (IPSEY) for $25.00 per share in cash upfront plus a CVR of $6.00 per share)
- GE +17% (to sell its BioPharma business to Danaher (DHR) for total consideration of $21.4 bln), DHR +6.4%
Select China related names showing strength:
- XNET +9.2%, BZUN +8.4%, MOMO +6.8%, WB +5.2%, CMCM +4.9%, JMEI +4.9%, JD +4.4%, VIPS +4.4%, YY +4.1%, WUBA +3.7%, EDU +3%, SOHU +2.9%, BABA +2.6%, BITA +2.5%, BIDU +2.4%, CAT +1.3%
Select Biotech stocks trading higher:
- QURE +17.3%, BOLD +15.4%, RGNX +10.8%, CRSP +10.5%, SGMO +9.9%, VYGR +6.9%, EDIT +6%, NTLA +4.9%, OPHT +4.3%, SRPT +4.3%, BMRN +4.1%
Select semiconductor related names showing strength following ONCE acquisition:
- STM +3.5%, MU +2.4%, AMD +2.3%, WDC +2.3%, XLNX +2%, NVDA +1.8%, QCOM +1.7%, ASML +1.5%
Other news:
- FENG +40.3% (announces letter of intent to sell 32% of the total outstanding shares of Particle Inc)
- INSY +8.4% (presented poster of initial pharmacokinetic study of epinephrine nasal spray for the emergency treatment of allergic reactions)
- BCRX +7.9% (reports ZENITH-1 results)
- FOLD +7.7% (granted FDA Breakthrough Therapy Designation for AT-GAA for the treatment of late onset Pompe disease)'
- AVP +6.5% (continued strength)
- STKL +3% (to sell its specialty and organic soy and corn business to Pipeline Foods for $66.5 mln)
- CSIQ +2% (continued strength)
- BHC +1.5% (FDA approval of LOTEMAX SM)
- NFLX +1.2% (Netflix won multiple Oscars last night)
Analyst comments:
- PLSE +4.1% (initiated with a Buy at H.C. Wainwright)
- INFN +3.6% (upgraded to Neutral from Sell at MKM Partners)
- NCLH +2% (upgraded to Outperform from Neutral at Macquarie)
- CBOE +1.5% (upgraded to Overweight from Neutral at JP Morgan)
